Global Sjogrens Syndrome Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	160 Pages	TechNavio	July, 2024	INF19287115

Best Price Guarantee
Price	from $2,500
Length	160 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19287115

Global Sjogrens Syndrome Therapeutics Market 2023-2027

The sjogrens syndrome therapeutics market is forecasted to grow by USD 691.09 million during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the sjogrens syndrome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong drug pipeline for launching medicines, high prevalence and incidence of sjogren's syndrome, and initiatives and expected approvals of products.

Technavio's sjogrens syndrome therapeutics market is segmented as below:

By Application
Clinical
Hospital
By Type
Primary
Secondary
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing development of biologics as one of the prime reasons driving the sjogrens syndrome therapeutics market growth during the next few years. Also, increasing diagnostic tests and biomarkers and rising number of awareness programs will lead to sizable demand in the market.

The report on the sjogrens syndrome therapeutics market covers the following areas:

Sjogrens syndrome therapeutics market sizing
Sjogrens syndrome therapeutics market forecast
Sjogrens syndrome therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sjogrens syndrome therapeutics market vendors that include AbbVie Inc., ADVANZ PHARMA Corp., Biogen Inc., Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Horizon Therapeutics Plc, Johnson and Johnson, MorphoSys AG, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., RemeGen Ltd., Resolve Therapeutics LLC, Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and TearSolutions Inc.. Also, the sjogrens syndrome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Sjogrens Syndrome Therapeutics Market 2018 - 2022; Historic Market Size - Data Table on Global Sjogrens Syndrome Therapeutics Market 2018 - 2022 ($ million); 4.2 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 6.3 Clinical - Market size and forecast 2023-2028; Chart on Clinical - Market size and forecast 2023-2028 ($ million); Data Table on Clinical - Market size and forecast 2023-2028 ($ million); Chart on Clinical - Year-over-year growth 2023-2028 (%); Data Table on Clinical - Year-over-year growth 2023-2028 (%); 6.4 Hospital - Market size and forecast 2023-2028; Chart on Hospital - Market size and forecast 2023-2028 ($ million); Data Table on Hospital - Market size and forecast 2023-2028 ($ million); Chart on Hospital - Year-over-year growth 2023-2028 (%); Data Table on Hospital - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Primary - Market size and forecast 2023-2028; Chart on Primary - Market size and forecast 2023-2028 ($ million); Data Table on Primary - Market size and forecast 2023-2028 ($ million); Chart on Primary - Year-over-year growth 2023-2028 (%); Data Table on Primary - Year-over-year growth 2023-2028 (%); 7.4 Secondary - Market size and forecast 2023-2028; Chart on Secondary - Market size and forecast 2023-2028 ($ million); Data Table on Secondary - Market size and forecast 2023-2028 ($ million); Chart on Secondary - Year-over-year growth 2023-2028 (%); Data Table on Secondary - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 ADVANZ PHARMA; ADVANZ PHARMA - Overview; ADVANZ PHARMA - Product / Service; ADVANZ PHARMA - Key offerings; 12.4 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.5 Daiichi Sankyo Co. Ltd.; Daiichi Sankyo Co. Ltd. - Overview; Daiichi Sankyo Co. Ltd. - Product / Service; Daiichi Sankyo Co. Ltd. - Key news; Daiichi Sankyo Co. Ltd. - Key offerings; 12.6 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.7 Hikma Pharmaceuticals Plc; Hikma Pharmaceuticals Plc - Overview; Hikma Pharmaceuticals Plc - Business segments; Hikma Pharmaceuticals Plc - Key news; Hikma Pharmaceuticals Plc - Key offerings; Hikma Pharmaceuticals Plc - Segment focus; 12.8 Horizon Therapeutics Plc; Horizon Therapeutics Plc - Overview; Horizon Therapeutics Plc - Product / Service; Horizon Therapeutics Plc - Key offerings; 12.9 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.10 MorphoSys AG; MorphoSys AG - Overview; MorphoSys AG - Product / Service; MorphoSys AG - Key offerings; 12.11 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.12 Otsuka Holdings Co. Ltd.; Otsuka Holdings Co. Ltd. - Overview; Otsuka Holdings Co. Ltd. - Business segments; Otsuka Holdings Co. Ltd. - Key news; Otsuka Holdings Co. Ltd. - Key offerings; Otsuka Holdings Co. Ltd. - Segment focus; 12.13 RemeGen Ltd.; RemeGen Ltd. - Overview; RemeGen Ltd. - Product / Service; RemeGen Ltd. - Key offerings; 12.14 Resolve Therapeutics LLC; Resolve Therapeutics LLC - Overview; Resolve Therapeutics LLC - Product / Service; Resolve Therapeutics LLC - Key offerings; 12.15 TearSolutions Inc.; TearSolutions Inc. - Overview; TearSolutions Inc. - Product / Service; TearSolutions Inc. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Sjogrens Syndrome Therapeutics Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Application - Market share 2023-2028 (%); Exhibits33: Data Table on Application - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Application; Exhibits35: Data Table on Comparison by Application; Exhibits36: Chart on Clinical - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Clinical - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Clinical - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Clinical - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Hospital - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Hospital - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Hospital - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Hospital - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Application ($ million); Exhibits45: Data Table on Market opportunity by Application ($ million); Exhibits46: Chart on Type - Market share 2023-2028 (%); Exhibits47: Data Table on Type - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Type; Exhibits49: Data Table on Comparison by Type; Exhibits50: Chart on Primary - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Primary - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Primary - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Primary - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Secondary - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Secondary - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Secondary - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Secondary - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Type ($ million); Exhibits59: Data Table on Market opportunity by Type ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: ADVANZ PHARMA - Overview; Exhibits110: ADVANZ PHARMA - Product / Service; Exhibits111: ADVANZ PHARMA - Key offerings; Exhibits112: Bristol Myers Squibb Co. - Overview; Exhibits113: Bristol Myers Squibb Co. - Product / Service; Exhibits114: Bristol Myers Squibb Co. - Key news; Exhibits115: Bristol Myers Squibb Co. - Key offerings; Exhibits116: Daiichi Sankyo Co. Ltd. - Overview; Exhibits117: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits118: Daiichi Sankyo Co. Ltd. - Key news; Exhibits119: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits120: GlaxoSmithKline Plc - Overview; Exhibits121: GlaxoSmithKline Plc - Business segments; Exhibits122: GlaxoSmithKline Plc - Key news; Exhibits123: GlaxoSmithKline Plc - Key offerings; Exhibits124: GlaxoSmithKline Plc - Segment focus; Exhibits125: Hikma Pharmaceuticals Plc - Overview; Exhibits126: Hikma Pharmaceuticals Plc - Business segments; Exhibits127: Hikma Pharmaceuticals Plc - Key news; Exhibits128: Hikma Pharmaceuticals Plc - Key offerings; Exhibits129: Hikma Pharmaceuticals Plc - Segment focus; Exhibits130: Horizon Therapeutics Plc - Overview; Exhibits131: Horizon Therapeutics Plc - Product / Service; Exhibits132: Horizon Therapeutics Plc - Key offerings; Exhibits133: Johnson and Johnson Services Inc. - Overview; Exhibits134: Johnson and Johnson Services Inc. - Business segments; Exhibits135: Johnson and Johnson Services Inc. - Key news; Exhibits136: Johnson and Johnson Services Inc. - Key offerings; Exhibits137: Johnson and Johnson Services Inc. - Segment focus; Exhibits138: MorphoSys AG - Overview; Exhibits139: MorphoSys AG - Product / Service; Exhibits140: MorphoSys AG - Key offerings; Exhibits141: Novartis AG - Overview; Exhibits142: Novartis AG - Business segments; Exhibits143: Novartis AG - Key news; Exhibits144: Novartis AG - Key offerings; Exhibits145: Novartis AG - Segment focus; Exhibits146: Otsuka Holdings Co. Ltd. - Overview; Exhibits147: Otsuka Holdings Co. Ltd. - Business segments; Exhibits148: Otsuka Holdings Co. Ltd. - Key news; Exhibits149: Otsuka Holdings Co. Ltd. - Key offerings; Exhibits150: Otsuka Holdings Co. Ltd. - Segment focus; Exhibits151: RemeGen Ltd. - Overview; Exhibits152: RemeGen Ltd. - Product / Service; Exhibits153: RemeGen Ltd. - Key offerings; Exhibits154: Resolve Therapeutics LLC - Overview; Exhibits155: Resolve Therapeutics LLC - Product / Service; Exhibits156: Resolve Therapeutics LLC - Key offerings; Exhibits157: TearSolutions Inc. - Overview; Exhibits158: TearSolutions Inc. - Product / Service; Exhibits159: TearSolutions Inc. - Key offerings; Exhibits160: Inclusions checklist; Exhibits161: Exclusions checklist; Exhibits162: Currency conversion rates for US$; Exhibits163: Research methodology; Exhibits164: Information sources; Exhibits165: Data validation; Exhibits166: Validation techniques employed for market sizing; Exhibits167: Data synthesis; Exhibits168: 360 degree market analysis; Exhibits169: List of abbreviations